MS
SANA icon

Marc Stad’s Sana Biotechnology SANA Stock Holding History

Marc Stad’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,500,000
Closed -$23.2M – 64
2021
Q4 		$23.2M Hold
1,500,000
– – 0.27% 38
2021
Q3 		$33.8M Hold
1,500,000
– – 0.44% 37
2021
Q2 		$29.5M Hold
1,500,000
– – 0.38% 40
2021
Q1 		$50.2M Buy
+1,500,000
New +$48.8M 0.72% 31

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Marc Stad's SANA Position: Q1 2022 in Review

Marc Stad sold out of Sana Biotechnology (SANA) in Q1 2022, closing a stake of 1,500,000 shares — an estimated $23.2M sold.

Marc Stad first reported a position in SANA in Q1 2021 and held it in 4 quarters. The position peaked at $50.2M in Q1 2021. 117 funds tracked by Wall St. Rank hold SANA as of Q1 2022.

  • Marc Stad reported no remaining Sana Biotechnology position as of Q1 2022 after selling out during the quarter.
  • Marc Stad sold 1,500,000 Sana Biotechnology shares in Q1 2022, an estimated $23.2M.
  • Marc Stad first reported a position in Sana Biotechnology in Q1 2021 and held it in 4 quarters.
  • Marc Stad's Sana Biotechnology position peaked at $50.2M in Q1 2021.
  • 117 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2022.

Based on Dragoneer Investment Group's 13F filing for Q1 2022, filed 16 May 2022.